Denis Ribon - Profile and Investment Details

Investor Profile

Denis Ribon is a Venture Capital, Private Equity Firm based in Conroe, Texas, United States with a diverse investment portfolio that includes companies such as ImaBiotech, SUANFARMA, Clean Cells, Vetoquinol, NEFTYS.PHARMA, Quintiles, Tiama, Cair LGL, Deallus, Groupe CARSO, BIOProfile S.A., Prollenium, Polyplus-transfection S.A., Grand Frais, Micromed, Primo Group, NAMSA, Labco Diagnostics, iPP - Integrated Pathology Partnerships, Citieffe Holding, Citieffe s.r.l., ActiGraph, Provepharm Life Solutions, Centri Dentistici Primo, . Over time, Denis Ribon has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Denis Ribon is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Corporate Wellness, Wellness, Investment Management, Healthcare Innovation, Life Science, Medical Technologies, Business Development, Finance, Manufacturing, Biotechnology, Healthcare IT, Consumer Health, Medical Devices, Innovation, Social Impact, Renewable Energy, Medical, B2B, Health Tech, Pharmaceuticals, Healthcare Technology, Professional Development, Acquisitions may find it worthwhile to explore potential connections with Denis Ribon, as their portfolio suggests a familiarity and interest in this area.

Understanding Denis Ribon’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.